SpyGlass Pharma, Inc. (SGP NASDAQ) stock market data APIs
$28.7982
-0.16(-0.6%)
as of September 15, 2026
Try our APIs with
free plan!
SpyGlass Pharma, Inc. Financial Data Overview
Price chart is built with
Anychart
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.
Prev. Close
28.7982
Open
28.643
High
28.8776
Low
27.03
52 wk Range
17.06-32.44
Market Cap
969 M
Shares Outstanding
33 448 K
EPS
-0.59
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with SpyGlass Pharma, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SpyGlass Pharma, Inc. data using free add-ons & libraries
Get SpyGlass Pharma, Inc. Fundamental Data
SpyGlass Pharma, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -61 091 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-06
- EPS/Forecast: -0.48
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SpyGlass Pharma, Inc. News
New
SpyGlass Pharma Q2 GAAP EPS of -$0.59
* SpyGlass Pharma, Inc. press release [https://seekingalpha.com/pr/20611077-spyglass-pharma-reports-second-quarter-2026-financial-results-and-provides-corporate-updates] (SGP [https://seekingalpha.c...
MongoDB downgraded, Block upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Block, CrowdStrike, Fortinet, MongoDB, Mosaic, Palo Alto Networks, Unity Software, and More
Quick Read Buy-the-dip buyers erased a 600-point Dow decline on Monday; they will face a 700-point drop this morning. The Russell 2000 leads all major indices in 2026 with 6.3% year-to-date gains. Tr...
Reddit, KKR, and 2 Biotech IPOs Seeing the Love From Insiders
Four stocks seeing the most notable insider purchases in the past week or so were biotechs SpyGlass Pharma (NASDAQ: SGP) and Veradermics (NYSE: MANE), as well as KKR (NYSE: KKR) and Reddit (NYSE: RDDT...
Get SpyGlass Pharma, Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
